Results

Total Results: 859 records

Showing results for "last months".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - included observational studies and open-label followup extensions of RCTs reporting long-term (>6 months … Followup duration ranged from 6 months to 10 years. … to 60 subjects) found no difference versus placebo at 12 months in mean change in IRLS scale scores … No RCTs assessed patients with mild or moderate disease, and few lasted longer than 6 months. … Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
    September 06, 2023 - Since the last update, there are also emergent paradigm changes that should be recognized. … A key debate in the field in the last decade centers around equity, social determinants of health, and … The dispositions of the peer review comments are documented and may be published three months after
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_disposition-comments.pdf
    August 21, 2013 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … – it was 9.5 months – given that it was jail study 9.5 years does not make logical sense). … Results: yes to all of the above except the last question. Thank you. … No to the last question because overcoming the barriers to such research has not been adequately addressed … This population is held anywhere from a few days to a few months.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
    January 01, 2022 - In patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to <6 months) … 2 Background and Purpose Chronic pain is defined as pain lasting longer than 3 to 6 months … : Benefits of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months … Question 2: Harms of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
    May 09, 2016 - Treatment of DPN symptoms (pain, paresthesias, numbness) Diabetic peripheral neuropathy was last covered … studies, case series, case reports, and meeting abstracts Timing Studies for KQ1a must have at least 3 months … and for areas where high-quality reviews exist in English, will identify and assess recent relevant (last … We will also hand search other recent (last 5 years) relevant reviews to identify any additional articles … The disposition of comments for systematic reviews and technical briefs will be published three months
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_executive.pdf
    August 01, 2014 - , social communication and interaction, restricted and repetitive behaviors) in the short term (≤6 months … symptoms (e.g., motor, medical, mood/anxiety, irritability, and hyperactivity) in the short term (≤6 months … 3 KQ 1c: What are the longer term effects (>6 months) on core symptoms (e.g., social communication … KQ 1d: What are the longer term effects (>6 months) on commonly associated symptoms (e.g., motor, medical … Our last search was conducted in December 2013.
  7. effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
    May 26, 2016 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … authors describe the disparity subgroups in paragraph 3 and once again describe the subgroups in the last … With that said, however, this second to last paragraph on page 25 is redundant to what is in the Methods … paragraph of page 35; last paragraph on page 41; first paragraph on page 42). … You have taken a wide range of data over the last 35 years and sifted through many publications to
  8. effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
    January 01, 2013 - predictive value, when possible Support the unit of analysis chosen for exposure measurement (e.g., person-months … operationalizing exposure to these two medications, it would be insufficient to examine medication use in the last … The last column (G–I) represents scenarios where there are multiple exposures over time with different … accurate definitions available Support the unit of analysis chosen for exposure measurement (e.g., person-months
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
    May 01, 2025 - as 55% of solid organ transplant recipients experiencing at least one infection within the first 12 months … vulnerable to infections due to the immunosuppression required to prevent transplant rejection, which can last … Results were limited to English language studies on human participants and covered publications from the last … Patients in the treatment group used the oral mucosal protectant twice daily for three months. … In fact, some guidelines suggest avoiding any dental treatment for at least three months post- transplant
  10. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
    January 01, 2012 - depending on expert comments received on interventions issued for comment during the preceding 6 months … norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite suppressant for short-term (3 months … with a decision date set for April 17, 2012. 8 In April 2012, FDA extended the decision date three months … Administration for inclusion in its therapeutic goods registry for treating T2DM and obesity for up to 12 months … implantation, a mean excess weight loss of 29.8%, reduction of HbA1c from 8.4% at baseline to 7.0% after 6 months
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_consumer.pdf
    January 01, 2017 - Over time, attacks may last longer and may happen more often. … Allopurinol (Zyloprim®) and febuxostat (Uloric®) do not lower the risk of a gout attack in the first 6 months
  12. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - depending on expert comments received on interventions issued for comment during the preceding 6 months … Topics tracked since the last Potential High-Impact Interventions Report include an intranasal naloxone … Additionally, after 3 months, patients in the SA+F group had significantly greater reductions in total … : -14.5 percentage points) than either SA (baseline: 78.1%; 3 months: 75.0%; change: -3.1 percentage … Six-months outcomes of a randomised trial of supportive text messaging for depression and comorbid
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
    August 23, 2010 - We plan to restrict our search to literature published within the last 10 years as the modalities of … literature searches, as this is a project that will be completed in a relatively short time frame (7 months
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
    February 01, 2014 - We looked for data on these outcomes at the last reported time point. … Asian,24 and 7 percent unspecified other race.25 The mean or median disease duration ranged from 7 months … and reported on the IBDQ among patients who had undergone ileocolonic anastomosis within 6 to 24 months … The length of followup ranged from 8 weeks to 18 months for RCTs and up to 3.6 years in an observational … The longest RCT had only 18 months of followup, and the longest prospective study had less than 4 years
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - ), intermediate-term treatment duration (6 to <12 months), and long- term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to <12 months), and long-term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to <12 months), and long-term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to <12 months), and long- term treatment duration (≥12 months … 12 months), and long-term treatment duration (≥12 months) • We will assess available literature to
  16. effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-disposition-comments.pdf
    June 09, 2021 - than pre or post surgery to be more inclusive of non-operative trials-Bullet point 8: Would rephrase last … Page 10, last paragraph. Two few studies for testing for publication bias. … Page 18, last paragraph. … in the abstract and at 12 months among long-term survivors. … The last few statements on p. 50 were especially salient to this topic.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pilot-projects-supplementing-white-paper.pdf
    December 01, 2024 - assigned staff were undertrained on data) • Timeline (front-end data requisition and access required months … Content last reviewed November 2023. Agency for Healthcare Research and Quality. Rockville, MD. … Content last reviewed December 2022. Agency for Healthcare Research and Quality. Rockville, MD.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_disposition-comments.pdf
    January 01, 2012 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … Thank you Mehul Dalal (Public Reviewer) Introduction Abstract Pg ix – “Data Synthesis” 2nd to last … and Discussion Pg 118 – “Interpretation of findings of Key Questions 1 and 2” first paragraph, last … Suggest modifying the last sentence of this paragraph to reflect this point. … Pg 121 – last paragraph, last sentence • Suggest adding “race and ethnicity” as candidate variable of
  19. effectivehealthcare.ahrq.gov/sites/default/files/transcript_deliberativemethodswebinar.pdf
    April 19, 2012 - The last topic will provide an overview of the deliberation experiment taking place as part of AHRQ … Goold’s last point about sort of how the diversity really enhances the deliberations because the … single events or have a longer duration where deliberations may take place over several weeks or months … actually have the benefit of having a set of meetings that might take place over several weeks or months … review, which I mentioned, I hope you will please look for a piece based on this within the next few months
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
    July 01, 2009 - prototype currently captures, codifies and standardizes over 150 unique data elements per patient for 48 months … In the last month how many times have you needed to eat or drink something because you felt your blood … Have you taken any of the following herbs or over-the-counter medications in the last month? … Adjusted reductions in H-A1C (either baseline to lowest or baseline to last) attenuated some of the … With these critical factors in mind, DARTNet is poised to undertake a rapid expansion in the next 18 months

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: